On May 29, 2024, the U.S. Food and Drug Administration (“FDA”) released draft guidance titled Platform Technology Designation Program for Drug Development. The draft guidance describes the process for requesting and receiving...more
Two years ago today, the Nagoya Protocol on Access to Genetic Resources and the Fair and Equitable Sharing of Benefits from their Utilization to the Convention on Biological Diversity (“Protocol”) entered into international...more
10/13/2016
/ Biotechnology ,
Brazil ,
Due Diligence ,
EU ,
Genetic Materials ,
Germany ,
India ,
Inventions ,
Mexico ,
Natural Resources ,
Patent Applications ,
Patents ,
Pharmaceutical Industry ,
Popular ,
R&D ,
Recordkeeping Requirements ,
Regulatory Oversight ,
Scientific Research ,
South Africa ,
Switzerland ,
The Nagoya Protocol ,
UK